Companies / Sagimet Biosciences Inc. / Activity
Activity — Sagimet Biosciences Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Happel David CEO | Sell | Series A Common Stock | $64.9K | -12K -1.75% | 677,621 1.09% of shares | low |
| Feb 19, 2026 | Happel David CEO | Grant | Series A Common Stock | $0 | +128K +18.89% | 805,621 1.30% of shares | low |
| May 28, 2026 | Happel David CEO | Grant | Stock Option (Right to Buy) | — | +300K | 300,000 0.48% of shares | low |
| Feb 19, 2026 | Happel David CEO | Grant | Stock Option (Right to Buy) | — | +256K | 256,000 0.41% of shares | low |